The “Vials Market Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) – Global Industry Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
Due to the surging incidence of chronic and acute diseases, the pharmaceutical industry is booming. As many of the drugs are administered via injection, the expanding pharma sector is expected to propel the global vials market from $1,263.0 million in 2020 to $3,047.0 million by 2030, at an 8.6% CAGR between 2021 and 2030
Presently, the COVID-19 pandemic is wreaking havoc on the world, with more than 151 million cases and 3 million deaths recorded thus far. This has put the healthcare and pharma sectors under immense pressure to find a cure and a way to prevent the infection.
As a result, extensive research and development (R&D) has unearthed numerous drugs, many of which have already received the regulatory approval and are now being used worldwide. Since most of these drugs are injectables, the pandemic is impacting the vials market positively.
In the past, pharmaceutical and biotech companies dominated the vials market under the end user segment, and they will also witness the fastest growth in the usage of vials in the near future. As these firms manufacture drugs in bulk, they require vials in large numbers. The rising demand for more-effective drugs, owing to the increasing prevalence of chronic and acute diseases, is propelling the procurement of such products by biotech and pharma companies.
Europe is currently the most-productive vials market on account of the expansion of its pharmaceutical industry, presence of established industry players, rise in the awareness regarding the newly launched drugs, and high purchasing power of Europeans.
In the years to come, the demand for vials will likely witness the fastest surge in Asia-Pacific (APAC). Key vial and pharma companies in the region are increasing their production output to meet the increasing demand for COVID vaccines.
Major players in the global vials market include
- Phoenix Glass LLC
- Pacific Vial Manufacturing Inc.
- Hanna Instruments
- PIRAMIDA d.o.o.
- Acme Vial and Glass Company LLC
- SGD Pharma
- Stevanato Group
- SCHOTT AG
- Gerresheimer AG
- Corning Incorporated
- Amposan S.A.
- TricorBraun Inc.
- Borosil Limited
- Piramal Glass Limited
- Nipro Corporation
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Glass Type
4.1.2 By End User
126.96.36.199 Pharmaceutical and biotech companies
188.8.131.52.1 By filling technology
184.108.40.206.1.1 Volumetric filling
220.127.116.11.1.2 Liquid-level filling
18.104.22.168 Biomedical research organizations
4.2 Market Dynamics
22.214.171.124 Increasing preference for glass vials
126.96.36.199 Growing pharmaceutical industry
188.8.131.52 Rising production capacity of vial manufacturers
184.108.40.206 Increasing healthcare expenditure
220.127.116.11 Impact analysis of drivers on market forecast
18.104.22.168 High cost of vials
22.214.171.124 High risk of breakage
126.96.36.199 Impact analysis of restraints on market forecast
188.8.131.52 Increasing demand for vaccine packaging
4.3 Porter’s Five Forces Analysis
4.4 Impact of COVID-19
Chapter 5. Global Market Size and Forecast
5.1 By Glass Type
5.2 By End User
5.2.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
5.3 By Region
Chapter 6. Europe Market Size and Forecast
Chapter 7. North America Market Size and Forecast
Chapter 8. APAC Market Size and Forecast
Chapter 9. LATAM Market Size and Forecast
Chapter 10. MEA Market Size and Forecast
Chapter 11. Competitive Landscape
11.1 Recent Strategic Developments of Players
11.1.2 Product Launches
11.1.3 Agreements and Partnerships
11.2 Market Share Analysis of Key Players
11.3 List of Market Players and Their Offerings
Chapter 12. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/a166tn
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900